Daniel Piskorz (0000-0002-8615-5446)

Personal information

Biography

Dr. Daniel Leonardo Piskorz was born in Rosario city, Argentina, on December 14th, 1957. I am married to Alicia Susana and I am father of Ignacio, also medical doctor, and Gonzalo, systems engineer. I obtained my medical doctor degree at the Medical College of the Rosario National University, Argentina, on December 15th, 1982 and specialized in cardiology at the Rosario Emergency Hospital “Dr. Clemente Alvarez”. I was matriculated as cardiologist at Santa Fe 2nd Circumscription Medical College on November 10th, 1988 and as echocardiography specialist level three on July 4th, 1991. In October 11th, 2013 the Latinamerican Society of Hypertension granted me the title of Hypertension Specialist. I have been speaker at many international meetings developed in London, Rome, Milano, Sidney, Washington, Anaheim, Chicago, Barcelona, Istanbul, Kyoto and almost all main latinamerican cities. I have published approximately 150 original papers and reviews as main author in peer review national and international indexed journals and five books “Hypertension, epidemiology, physiology, physiopathology and treatment” on 2013, and “Cardiometabolism, from physiopathology to treatment” on 2014, the second edition on 2017, third edition in 2019 and fourth edition on 2022. I was the 2011 – 2013 President of the Argentina Hypertension Society and 2017 President of the Argentina Cardiology Federation, and I was member of the Board of Directors of the Latin-American Hypertension Society from 2013 to 2019 and from 2022, 2018-2020 Coordinator of the Epidemiology and Cardiovascular Prevention Council of the Interamerican Society of Cardiology, and 2019 Governor of the Argentina Chapter of the American College of Cardiology. Actually, I am Deputy Chair of the International Society of Hypertension America´s Regional Group, Member-at-Large of the Interamerican Heart Foundation, Argentina Governor of the Interamerican Society of Hypertension and Argentina Governor of the International Society of Cardiovascular Pharmacotherapy. I am member of the International Society of Hypertension, Overseas Affiliated Member of the British and Irish Hypertension Society, Fellow of the American College of Cardiology, Fellow of the Interamerican Society of Cardiology and Emeritus Member of the Spanish Cardiology Society. My main point of interest is hypertension and cardiovascular disease.
Address: Central Argentino 144 - 2000 Rosario - Argentina
Phone: +54 - 0341 - 4382884
Mobile phone: +54 – 9 - 341 – 5 - 416828
E-mail: Daniel.l.piskorz@gmail.com

Activities

Collapse all

Items per page:

Page 1 of 4

HYPERTENSION PHENOTYPES BASED ON BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH HYPERTENSION PHENOTYPES BASED ON BOTH BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH LEFT VENTRICULAR HYPERTROPHY: FINDINGS FROM THE I24ABC CONSORTIUM

Journal of Hypertension

2024 | Journal article

DOI: 10.1097/01.HJH.0001021472.07396.E2

WOSUID: WOS:001256619700535

Contributors: Athanasopoulou, Elpida; Weber, Thomas; Wassertheurer, Siegfried; Sharman, James E.; Argyris, Antonios; Sala, Enrique Rodilla; Jankowski, Piotr; Muiesan, Maria Lorenza; Giannattasio, Cristina; Wilkinson, Ian et al.

Daniel Piskorz

https://orcid.org/0000-0002-8615-5446

Personal information

Other IDs

Biography

Activities

Works (50 of 179)

HYPERTENSION PHENOTYPES BASED ON BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH HYPERTENSION PHENOTYPES BASED ON BOTH BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH LEFT VENTRICULAR HYPERTROPHY: FINDINGS FROM THE I24ABC CONSORTIUM

Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk

The Introduction

Violence and aggression against nurses during the COVID-19 pandemic in Latin America. From the emerging leaders program of the Interamerican Society of Cardiology (SIAC)

Challenges in Worldwide Cardiovascular Urgencies and Emergencies

Inflammation as therapeutic target in the cardiovascular continuum

Correction: The Rationale for Using Fixed‑Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review

Metabolic biomarkers and cardiovascular risk stratification in hypertension

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Latin-American guidelines of recommendations at discharge from an acute coronary syndrome

Latin-American guidelines of recommendations at discharge from an acute coronary syndrome

The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review

Antagonistas mineralocorticoideo en el continuo cardio-nefro-metabólico: rol emergente de la finerenona.

Blood pressure telemonitoring and telemedicine, a Latin America perspective

Blood pressure telemonitoring and telemedicine, a Latin America perspective

CLINICAL RESEARCH IN LATIN AMERICA: FROM SPONSORED TO INVESTIGATOR INITIATED RESEARCH

Comparative pharmacological profile and cardiovascular impact of classic and emergent mineralocorticoid antagonist receptors

DIASTOLIC DYSFUNCTION, HYPERTROPHY AND HYPERTENSION VENTRICULAR-ARTERIAL UNCOUPLING TREATMENT

HOW TO ASSESS BENEFICIAL EFFECTS OF ANTIHYPERTENSIVE TREATMENTS

Hypertension and target organ damage in cardiometabolic patients

Increased pulse wave velocity, ventricular coupling and cardiac remodeling

Position of the Argentine Federation of Cardiology on the Intersocietal Document that warns about the high prevalence of cardiovascular and renal complications in people with type 2 diabetes in Argentina

Preface

Puesta al día en antiinflamatorios

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Tratamiento de la obesidad desde una perspectiva cardiovascular

Treatment of obesity from a cardiovascular perspective

Update on antiinflammatories

Violence and aggression against nurses during the COVID-19 pandemic in Latin America. From the emerging leaders program of the Interamerican Society of Cardiology (SIAC).

Which systolic blood pressure shows closest associations with left ventricular mass? The International 24 Hour Aortic Blood Pressure Consortium (I24ABC)

WHICH SYSTOLIC BLOOD PRESSURE SHOWS CLOSEST ASSOCIATIONS WITH LEFT VENTRICULAR MASS? THE INTERNATIONAL 24 HOUR AORTIC BLOOD PRESSURE CONSORTIUM (I24ABC)

Hipertensión arterial y daño en órgano blanco en pacientes cardiometabólicos

Posición de la Federación Argentina de Cardiología acerca del Documento intersocietario que alerta sobre la alta prevalencia de complicaciones cardiovasculares y renales en personas con diabetes tipo 2 en Argentina

Optimization of coronary bifurcation angioplasty by intravascular ultrasound

PROF. DR. HECTOR LUCAS LUCIARDI - In Memoriam

Blood pressure telemonitoring and telemedicine for hypertension management—positions, expectations and feasibility of Latin–American practitioners. SURVEY carried out by several cardiology and hypertension societies of the Americas

The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice - The VIPFARMA ISCP Project.

Diastolic dysfunction, hypertrophy and hypertension ventricular-arterial uncoupling treatment

El control de la hipertensión arterial, una asignatura pendiente

Ventricular-Arterial Uncoupling and Hypertension Mediated Diastolic Dysfunction

Optimización mediante ultrasonido intravascular de la angioplastía de bifurcación coronaria.

Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units

Positioning on GLP-1 receptor agonists

Temporary sinus bradycardia and COVID-19 Report of a case and review of the bibliography

WHEN SOULD WE CONSIDER PRIMARY HYPERALDOSTERONISM IN A CASE OF TREATMENTRESISTANT HYPERTENSION? DIAGNOSIS AND MANAGEMENT

¿Cuándo pensar en hiperaldosteronismo primario ante un caso de hipertensión resistente al tratamiento? Diagnóstico y manejo.

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation

Optimization by intravascular ultrasound of left main coronary artery angioplasty

Peer review (185 reviews for 55 publications/grants)